4//SEC Filing
Apuli Maricel 4
Accession 0000950170-25-043376
CIK 0001743881other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 6:03 PM ET
Size
5.2 KB
Accession
0000950170-25-043376
Insider Transaction Report
Form 4
Apuli Maricel
Chief Accounting Officer
Transactions
- Award
Common Stock
2025-03-19+23,660→ 148,665 total
Footnotes (2)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2025, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0002058197
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 6:03 PM ET
- Size
- 5.2 KB